USFDA completes inspection at SMS Lifesciences India’s API manufacturing facility

09 Apr 2022 Evaluate

The United States Food and Drug Administration (USFDA) has completed inspection at SMS Lifesciences India’s API manufacturing facility located at Sy. No. 180/2, Kazipally, Jinnaram Mandal, Sangareddy district, Telangana (Unit I), without any observations. The inspection commenced on April 4, 2022 and concluded on April 8, 2022.

SMS Lifesciences India is presently engaged in the business of manufacturing, buying, selling, offering consultancy, importing and exporting, acting as commission agents and generally dealing with of all types of Organic & Inorganic Chemicals, Pharmaceuticals, API and Intermediates.

SMS Lifesciences Share Price

1421.00 29.00 (2.08%)
31-Oct-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1849.05
Dr. Reddys Lab 1274.25
Cipla 1553.20
Lupin 2184.00
Zydus Lifesciences 1001.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.